2016
Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial Infarction
Lopes RD, Pieper KS, Stevens SR, Solomon SD, McMurray JJ, Pfeffer MA, Leimberger JD, Velazquez EJ. Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial Infarction. Journal Of The American Heart Association 2016, 5: e003045. PMID: 27353607, PMCID: PMC4937254, DOI: 10.1161/jaha.115.003045.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedEpidemiologic MethodsFemaleHeart FailureHospitalizationHumansMaleMiddle AgedMyocardial InfarctionPrognosisVentricular Dysfunction, LeftConceptsVentricular systolic dysfunctionHeart failureMyocardial infarctionIntegrated discrimination improvementSystolic dysfunctionCardiovascular deathMultivariable Cox proportional hazardsAcute Myocardial Infarction trialNet reclassification improvement indexNonfatal heart failureMyocardial Infarction trialNonfatal myocardial infarctionPredictors of mortalityPatient informationBaseline heart rateAcute myocardial infarctionCox proportional hazardsCreatinine clearanceHospital arrivalHospital dischargeIndex hospitalizationPatient characteristicsOverall mortalityIndex eventClinical events
2010
Impact of early surgery on survival of patients with severe mitral regurgitation
Samad Z, Kaul P, Shaw LK, Glower DD, Velazquez EJ, Douglas PS, Jollis JG. Impact of early surgery on survival of patients with severe mitral regurgitation. Heart 2010, 97: 221. PMID: 21071750, DOI: 10.1136/hrt.2010.202432.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsAgedEpidemiologic MethodsFemaleHumansMaleMiddle AgedMitral Valve InsufficiencyNorth CarolinaPrognosisTime FactorsTreatment OutcomeConceptsSevere mitral regurgitationDegenerative mitral regurgitationEarly surgery groupLate surgery groupEarly surgeryMitral regurgitationSurgery groupLate surgeryGuideline indicationsOptimal timingValve diseaseMV repairAdjusted Cox regression modelCongenital mitral valve diseaseValve repair/replacementSevere degenerative mitral regurgitationACC/AHA guideline recommendationsSevere valve diseaseSurvival of patientsTiming of surgeryMitral valve diseaseCox regression modelLong-term survivalEarly referralCoronary diseaseAtrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial
Nilsson KR, Al-Khatib SM, Zhou Y, Pieper K, White HD, Maggioni AP, Kober L, Granger CB, Lewis EF, McMurray JJ, Califf RM, Velazquez EJ. Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial. Heart 2010, 96: 838. PMID: 20406769, DOI: 10.1136/hrt.2009.180182.Peer-Reviewed Original ResearchMeSH KeywordsAgedAnti-Arrhythmia AgentsAtrial FibrillationEpidemiologic MethodsFemaleHeart FailureHumansMaleMyocardial InfarctionStrokeVentricular Dysfunction, LeftConceptsRhythm control strategyAcute Myocardial Infarction trialMyocardial Infarction trialAtrial fibrillationMyocardial infarctionRate control strategyEarly mortalityAnti-arrhythmic drug therapyTreatment of AFPeri-infarct periodIncidence of strokeManagement of patientsRisk of deathLate mortalityPatient populationDrug therapyCox modelPatientsMortalityInfarctionStrokeValsartanTrialsDeathDays